Lantern Pharma Correlations

LTRN Stock

USD 4.05 0.08 2.02%

The current 90-days correlation between Lantern Pharma and Beam Therapeutics is 0.29 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lantern Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lantern Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Lantern Pharma Correlation With Market

Significant diversification

The correlation between Lantern Pharma and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.

Moving together with Lantern Stock

0.63	A	Agilent Technologies	Pair Corr
0.65	FENC	Fennec Pharmaceuticals	Pair Corr
0.71	CUE	Cue Biopharma	Pair Corr
0.9	OPT	Opthea	Pair Corr
0.74	GANX	Gain Therapeutics	Pair Corr
0.67	PHGE	Biomx Inc	Pair Corr
0.65	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.83	OBI	Ondine Biomedical	Pair Corr
0.62	SSNLF	Samsung Electronics	Pair Corr

Moving against Lantern Stock

0.74	INZY	Inozyme Pharma	Pair Corr
0.7	ABOS	Acumen Pharmaceuticals	Pair Corr
0.51	ILMN	Illumina	Pair Corr
0.48	KURA	Kura Oncology	Pair Corr
0.34	NAMSW	NewAmsterdam Pharma	Pair Corr
0.72	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.69	ADTX	Aditxt Inc	Pair Corr
0.64	TCRX	Tscan Therapeutics	Pair Corr
0.64	TERN	Terns Pharmaceuticals	Pair Corr
0.49	CTMX	CytomX Therapeutics	Pair Corr
0.44	DAWN	Day One Biopharmaceu	Pair Corr
0.41	STRO	Sutro Biopharma	Pair Corr
0.74	U4R90AAB4	HLF 4875 01	Pair Corr
0.67	TLKMF	Telkom Indonesia Tbk	Pair Corr
0.49	PTAIY	Astra International Tbk	Pair Corr
0.39	TLK	Telkom Indonesia Tbk	Pair Corr

Related Correlations Analysis

	BEAM	EDIT	CRBU	VERV	NTLA	FATE	REGN	NVO	SRPT	HEPA
BEAM		0.28	-0.18	0.47	0.08	-0.01	-0.11	-0.02	-0.23	-0.32	BEAM
EDIT	0.28		0.48	-0.17	0.68	0.68	0.53	0.62	-0.1	0.36	EDIT
CRBU	-0.18	0.48		-0.6	0.9	0.87	0.86	0.84	0.67	0.9	CRBU
VERV	0.47	-0.17	-0.6		-0.46	-0.45	-0.49	-0.44	-0.32	-0.79	VERV
NTLA	0.08	0.68	0.9	-0.46		0.9	0.86	0.89	0.5	0.77	NTLA
FATE	-0.01	0.68	0.87	-0.45	0.9		0.79	0.83	0.54	0.76	FATE
REGN	-0.11	0.53	0.86	-0.49	0.86	0.79		0.87	0.53	0.79	REGN
NVO	-0.02	0.62	0.84	-0.44	0.89	0.83	0.87		0.45	0.7	NVO
SRPT	-0.23	-0.1	0.67	-0.32	0.5	0.54	0.53	0.45		0.6	SRPT
HEPA	-0.32	0.36	0.9	-0.79	0.77	0.76	0.79	0.7	0.6		HEPA
	BEAM	EDIT	CRBU	VERV	NTLA	FATE	REGN	NVO	SRPT	HEPA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NTLA	+ 0.9	CRBU
HEPA	+ 0.9	CRBU
FATE	+ 0.9	NTLA
NVO	+ 0.89	NTLA
FATE	+ 0.87	CRBU
NVO	+ 0.87	REGN

High negative correlations

HEPA	- 0.79	VERV
VERV	- 0.6	CRBU
REGN	- 0.49	VERV
NTLA	- 0.46	VERV
FATE	- 0.45	VERV
NVO	- 0.44	VERV

Risk-Adjusted Indicators

There is a big difference between Lantern Stock performing well and Lantern Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lantern Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BEAM	3.40	0.24	0.06	0.24	3.78	(3.74)	8.04	(7.45)	21.42
EDIT	6.37	0.24	0.03	0.11	8.46	(7.74)	12.04	(9.59)	119.53
CRBU	3.00	(0.63)	0.00	(1.55)	0.00	0.00	8.22	(7.09)	17.35
VERV	5.44	0.78	0.15	0.28	4.82	(6.53)	11.24	(7.99)	36.90
NTLA	3.59	(0.32)	0.00	0.54	0.00	0.00	7.84	(7.15)	22.98
FATE	5.42	(0.71)	0.00	(0.31)	0.00	0.00	11.34	(11.47)	34.46
REGN	1.41	(0.07)	0.00	0.13	0.00	0.00	2.15	(3.61)	8.14
NVO	2.05	(0.16)	0.00	0.73	0.00	0.00	4.36	(3.62)	20.40
SRPT	1.74	0.06	0.03	(0.23)	2.19	(1.86)	3.98	(4.04)	19.63
HEPA	7.67	(1.29)	0.00	(1.46)	0.00	0.00	17.65	(11.11)	86.86

Lantern Pharma Corporate Management

DVM MS	CoFounder Advisor	Profile
Nicole Leber	Finance Associate	Profile
MS BS	Head Operations	Profile
Kishor Bhatia	Chief Consultant	Profile
Marc MD	Chief Therapeutics	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC